Page 9 - Toby Maher News Today : Breaking News, Live Updates

Vicore's AIR study interim analysis suggests that C21 improves lung function in IPF patients

Published: February 10, 2022

/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2...

Source: prnewswire.co.uk

Related Topics:

Vicore's AIR study interim analysis suggests that C21 improves lung function in IPF patients

Published: February 10, 2022

/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2...

Source: prnewswire.com

Related Topics:

United Kingdom Vastra Gotalands Lan Toby Maher Rohit Batta Joanna Porter Carl Johan Dalsgaard Prnewswire Vicore Pharma Holding Vicore Pharma Holding Forced Vital Capacity Professor Toby Maher Professor Joanna Porter Chief Medical Officer Johan Dalsgaard Pharma Holding Vicore Pharma Holding Ab Health Care Amp Hospitals Pharmaceuticals Medical Pharmaceuticals Clinical Trials Amp Medical Discoveries

Vicore Pharma Holding AB: Vicore's AIR study interim analysis suggests that C21 improves lung function in IPF patients

Published: February 10, 2022

GOTHENBURG, Sweden, Feb. 10, 2022 /PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2

Source: finanznachrichten.de

Related Topics:

United Kingdom Vastra Gotalands Lan Toby Maher Rohit Batta Joanna Porter Carl Johan Dalsgaard Prnewswire Vicore Pharma Holding Vicore Pharma Holding Forced Vital Capacity Professor Toby Maher Professor Joanna Porter Chief Medical Officer Johan Dalsgaard

Vicore's AIR study interim analysis suggests that C21 improves lung function in IPF patients

Published: February 10, 2022

/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2...

Source: prnewswire.com

Related Topics:

United Kingdom Vastra Gotalands Lan Toby Maher Rohit Batta Joanna Porter Carl Johan Dalsgaard Prnewswire Vicore Pharma Holding Vicore Pharma Holding Forced Vital Capacity Professor Toby Maher Professor Joanna Porter Chief Medical Officer Johan Dalsgaard Pharma Holding Vicore Pharma Holding Ab Health Care Amp Hospitals Pharmaceuticals Medical Pharmaceuticals Clinical Trials Amp Medical Discoveries

Investegate |PureTech Health PLC Announcements | PureTech Health PLC: LYT-100 Shows Improved AE Profile vs Pirfenidone

Published: January 6, 2022

Investegate announcements from PureTech Health PLC, LYT-100 Shows Improved AE Profile vs Pirfenidone

Source: investegate.co.uk

Page 9 - Toby Maher News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Top News In Toby Maher Today - Breaking & Trending Today

Vicore's AIR study interim analysis suggests that C21 improves lung function in IPF patients

Vicore's AIR study interim analysis suggests that C21 improves lung function in IPF patients

Vicore Pharma Holding AB: Vicore's AIR study interim analysis suggests that C21 improves lung function in IPF patients

Vicore's AIR study interim analysis suggests that C21 improves lung function in IPF patients

Investegate |PureTech Health PLC Announcements | PureTech Health PLC: LYT-100 Shows Improved AE Profile vs Pirfenidone